立体定向体部放疗与手术治疗美国退伍军人早期肺癌的比较
该研究基于退伍军人事务系统2006至2015年收治的4069例活检证实的临床I期非小细胞肺癌患者,比较肺叶切除、亚肺叶切除与立体定向体部放疗(SBRT)的癌症特异性生存。多变量竞争风险分析显示,SBRT的癌症特异性死亡风险高于肺叶切除(亚分布风险比1.45,95%CI 1.09-1.94,p=0.01),但与亚肺叶切除无生存差异(亚分布风险比1.25,95%CI 0.93-1.68,p=0.15)。
要点
- 纳入4069例临床I期非小细胞肺癌退伍军人,其中SBRT 449例、肺叶切除2986例、亚肺叶切除634例。
- 多变量分析示SBRT癌症特异性死亡风险高于肺叶切除(亚分布风险比1.45,95%CI 1.09-1.94,p=0.01)。
- SBRT与亚肺叶切除的癌症特异性生存无显著差异(亚分布风险比1.25,95%CI 0.93-1.68,p=0.15)。
核心结论
- 在大量早期肺癌患者 cohort 中,肺叶切除的生存优于SBRT,但亚肺叶切除与SBRT之间无生存差异。
- 原文指出仍存在未测量混杂的可能性,需要前瞻性随机试验来更好地比较这些治疗方式。
研究设计与样本
- 研究利用退伍军人事务信息与计算基础设施数据库,识别2006年至2015年间诊断为活检证实的临床I期非小细胞肺癌的退伍军人。
- 共纳入4069例患者,其中SBRT 449例、肺叶切除2986例、亚肺叶切除634例。
- 采用单变量和多变量竞争风险分析比较癌症特异性生存,多变量分析校正了术前肺功能、吸烟状态、合并症及分期检查程序等混杂因素。
主要发现
- 未校正分析发现手术组术后即刻死亡率高于SBRT组。
- 多变量分析考虑长期生存时,SBRT的癌症特异性死亡风险高于肺叶切除(亚分布风险比1.45,95%CI 1.09-1.94,p=0.01)。
- SBRT与亚肺叶切除之间无生存差异(亚分布风险比1.25,95%CI 0.93-1.68,p=0.15)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出仍存在未测量混杂的可能性。
- 原文指出需要前瞻性随机试验来更好地比较这些治疗方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stereotactic body radiation therapy (SBRT) has been proposed as a potential alternative to surgery for early lung cancer, although we lack well-powered prospective randomized data comparing these treatments, and existing studies suffer from incomplete information on confounders that can bias results. Here, we evaluated the comparative effectiveness of surgery and SBRT in lung cancer treatment using a large extensively detailed database from the Veteran's Affairs system. METHODS: We identified veterans with biopsy-proven clinical stage I non-small cell lung cancer diagnosed between 2006 and 2015 from within the Veteran's Affairs Informatics and Computing Infrastructure. We compared cancer-specific survival among patients receiving lobectomy, sublobar resection, or SBRT using univariable and multivariable competing risk analyses. Multivariable analyses adjusted for confounders including preoperative pulmonary function, smoking status, comorbidity, and staging workup procedures. RESULTS: In all, 4,069 patients were included (449 SBRT, 2,986 lobectomy, 634 sublobar resection). Unadjusted analysis found higher immediate postprocedural mortality in the surgery groups compared with the SBRT group. The multivariable analysis considering long-term survival found higher cancer-specific mortality for SBRT compared with lobectomy (subdistribution hazard ratio 1.45, 95% confidence interval: 1.09 to 1.94, p = 0.01), although no survival difference between SBRT and sublobar resection (subdistribution hazard ratio 1.25, 95% confidence interval: 0.93 to 1.68, p = 0.15). CONCLUSIONS: Among a large cohort of early stage lung cancer patients, we found that lobectomy had improved survival compared with SBRT, although we found no survival difference between sublobar resection and SBRT. Despite these findings, the potential for unmeasured confounding remains and prospective randomized trials are needed to better compare these treatment modalities.
引用
- Bryant AK, Mundt RC, Sandhu AP, et al. Stereotactic Body Radiation Therapy Versus Surgery for Early Lung Cancer Among US Veterans. Ann Thorac Surg. 2017. PMID: 29198624. doi:10.1016/j.athoracsur.2017.07.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。